- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 477/00 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycinsSuch ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Patent holdings for IPC class C07D 477/00
Total number of patents in this class: 16
10-year publication summary
|
0
|
2
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dainippon Sumitomo Pharma Co., Ltd. | 174 |
3 |
| Southern Methodist University | 120 |
2 |
| University of Central Florida Research Foundation, Inc. | 1232 |
2 |
| The Johns Hopkins University | 5821 |
1 |
| Cadila Healthcare Limited | 301 |
1 |
| Daiichi Sankyo Company, Limited | 1888 |
1 |
| Lek Pharmaceuticals d.d. | 189 |
1 |
| Meiji Seika Kaisha, Ltd. | 51 |
1 |
| Ranbaxy Laboratories Limited | 270 |
1 |
| Regents of the University of Minnesota | 2768 |
1 |
| Rutgers, The State University of New Jersey | 1959 |
1 |
| Savior Lifetec Corporation | 9 |
1 |
| Other owners | 0 |